Key Market Indicators
The Netherlands is projected to see its insulin imports rise to approximately $230 million by 2028, up from around $209 million in 2023. This represents an average annual growth rate of 1.4%. Since 1997, demand for insulin in the country has consistently increased, showing a yearly rise of 2%. In contrast, Dutch insulin exports have experienced a significant decline. In 2018, exports were close to $779,000, a drop from nearly $989,000 in 2017, marking a 21.2% decrease. Over the longer term, Dutch insulin supply has faced a sharp downturn, falling by 39.6% annually since 1997.
